Encephalitis:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Encephalitis Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Encephalitis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Encephalitis 23
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Encephalitis Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Valneva SE 31
Clinical Trial Overview of Valneva SE 31
Baxter International Inc. 32
Clinical Trial Overview of Baxter International Inc. 32
Sanofi 34
Clinical Trial Overview of Sanofi 34
Novartis AG 35
Clinical Trial Overview of Novartis AG 35
Biological E. Limited 36
Clinical Trial Overview of Biological E. Limited 36
Microgen Scientific Industrial Company for Immunobiological Medicines 37
Clinical Trial Overview of Microgen Scientific Industrial Company for Immunobiological Medicines 37
Baxter Healthcare Corporation 38
Clinical Trial Overview of Baxter Healthcare Corporation 38
Pharmaceutical Product Development, LLC 39
Clinical Trial Overview of Pharmaceutical Product Development, LLC 39
Pfizer Inc. 40
Clinical Trial Overview of Pfizer Inc. 40
Novartis Vaccines and Diagnostics GmbH & Co. KG 41
Clinical Trial Overview of Novartis Vaccines and Diagnostics GmbH & Co. KG 41
Sanofi Pasteur Korea 42
Clinical Trial Overview of Sanofi Pasteur Korea 42
Sanofi Pasteur SA 43
Clinical Trial Overview of Sanofi Pasteur SA 43
Hoffmann-La Roche Inc. 44
Clinical Trial Overview of Hoffmann-La Roche Inc. 44
DynPort Vaccine Company LLC 45
Clinical Trial Overview of DynPort Vaccine Company LLC 45
MacroGenics, Inc. 46
Clinical Trial Overview of MacroGenics, Inc. 46
Bharat Biotech International Limited 47
Clinical Trial Overview of Bharat Biotech International Limited 47
Baxter Deutschland GmbH 48
Clinical Trial Overview of Baxter Deutschland GmbH 48
Boryung Pharmaceutical Co., Ltd. 49
Clinical Trial Overview of Boryung Pharmaceutical Co., Ltd. 49
Intercell AG 50
Clinical Trial Overview of Intercell AG 50
Clinical Trial Overview of Top Institutes / Government 51
The National Institute of Allergy and Infectious Diseases 51
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 51
Program for Appropriate Technology in Health 52
Clinical Trial Overview of Program for Appropriate Technology in Health 52
U.S. Army Medical Research and Materiel Command 53
Clinical Trial Overview of U.S. Army Medical Research and Materiel Command 53
Medical University of Vienna 54
Clinical Trial Overview of Medical University of Vienna 54
Indian Council of Medical Research 55
Clinical Trial Overview of Indian Council of Medical Research 55
Emory University 56
Clinical Trial Overview of Emory University 56
Sormland County Council 57
Clinical Trial Overview of Sormland County Council 57
Chhatrapati Shahuji Maharaj Medical University 58
Clinical Trial Overview of Chhatrapati Shahuji Maharaj Medical University 58
Institut fur Speziale Prophylaxe und Tropenmedizin 59
Clinical Trial Overview of Institut fur Speziale Prophylaxe und Tropenmedizin 59
Medical Research Council 60
Clinical Trial Overview of Medical Research Council 60
University of Michigan 61
Clinical Trial Overview of University of Michigan 61
Helsinki University Central Hospital 62
Clinical Trial Overview of Helsinki University Central Hospital 62
The University of Liverpool 63
Clinical Trial Overview of The University of Liverpool 63
Drugs for Neglected Diseases initiative 64
Clinical Trial Overview of Drugs for Neglected Diseases initiative 64
West Virginia University 65
Clinical Trial Overview of West Virginia University 65
Assistance Publique – Hopitaux de Paris 66
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 66
University Health Network 67
Clinical Trial Overview of University Health Network 67
University Hospital, Bonn 68
Clinical Trial Overview of University Hospital, Bonn 68
University Medical Centre Ljubljana 69
Clinical Trial Overview of University Medical Centre Ljubljana 69
London School of Hygiene & Tropical Medicine 70
Clinical Trial Overview of London School of Hygiene & Tropical Medicine 70
Five Key Clinical Profiles 71
Appendix 92
Abbreviations 92
Definitions 92
Research Methodology 93
Secondary Research 94
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 95


【レポート販売概要】

■ タイトル:Encephalitis:グローバル臨床試験レビューH2, 2013
■ 英文:Encephalitis Global Clinical Trials Review, H2, 2013
■ 発行日:2013年9月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162157
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。